Chevron Sees Path to Boost Venezuela Oil Output by 50% After Trump Administration Talks 
FTC Blocks Edwards Lifesciences’ JenaValve Acquisition in Major Antitrust Ruling 
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan 
OpenAI Sets $50 Billion Stock Grant Pool, Boosting Employee Equity and Valuation Outlook 
FCC Exempts Select Foreign-Made Drones From U.S. Import Ban Until 2026 
Boeing 737 MAX 10 Advances in FAA Testing as Certification Delays Continue 
Rio Tinto–Glencore Merger Talks Spark Investor Debate Over Value, Strategy and Coal Exposure 
GM Takes $6 Billion EV Write-Down as Electric Vehicle Demand Slows in the U.S. 
Nvidia Appoints Former Google Executive Alison Wagonfeld as First Chief Marketing Officer 
Samsung Forecasts Strong Q4 Profit on AI-Driven Memory Chip Boom 
Trump Calls for 10% Credit Card Interest Rate Cap Starting 2026 
Ford Targets Level 3 Autonomous Driving by 2028 with New EV Platform and AI Innovations 
Vitol to Ship First U.S. Naphtha Cargo to Venezuela Under New Oil Supply Deal 
Elon Musk Says X Will Open-Source Its Algorithm Amid EU Scrutiny 
AustralianSuper Backs BlueScope Steel’s Rejection of $9 Billion Takeover Bid 
FCC Approves Expansion of SpaceX Starlink Network With 7,500 New Satellites 
BRIGHTON, Colo., March 19, 2017 -- Brighton Eye Associates is pleased to announce to the community the introduction of the High Definition CIRRUS HD-OCT technology as part of an enhanced eye examination. The Ocular Coherence Tomography or OCT provides a microscopic 3-D evaluation of the eye. Especially important is its use for macular degeneration and for glaucoma. It is also valuable for other eye conditions including diabetes and high blood pressure. Doctors are able to see the difference between wet macular degeneration and dry macular degeneration.
Glaucoma is usually seen in people over the age of 40. People do not know they have glaucoma because it has no symptoms. Early detection, monitoring, and treatment slows the progress of glaucoma. The new High Definition CIRRUS HD-OCT instrument allows for a 3D examination of the eye and much earlier diagnosis of glaucoma.
“We are excited to offer the new HD OCT instrument to our patients,” said Dr. Rodney D. Fair, OD. “Dr. Baker, Dr. Sanchez and I are always looking for better ways to serve the vision needs of our patients and this instrument is the latest addition to our state-of-the-art technology used to help our patients at Brighton Eye Associates.”
Visit http://brightoneye.net/ for more details.
Brighton Eye Associates 1001 E. Bridge Street Brighton, CO 80601 (303) 659-3036
